Annotations for this protein have been verified by the authors of the corresponding papers



DP00492: Androgen receptor [Isoform 1 (AR-B)]FASTA viewXML view

General information
DisProt:DP00492
Name:Androgen receptor [Isoform 1 (AR-B)]
Synonym(s):ANDR_HUMAN
Dihydrotestosterone receptor
Nuclear receptor subfamily 3 group C member 4
First appeared in release:Release 3.2 (05/26/2006)
UniProt:P10275-1
UniGene:Hs.496240
SwissProt: ANDR_HUMAN
TrEMBL:  
NCBI (GI): 113830
Source organism:Homo sapiens (Human)
Sequence length:919
Percent disordered:37%
Homologues: 


Native sequence

        10         20         30         40         50         60
         |          |          |          |          |          |
MEVQLGLGRV YPRPPSKTYR GAFQNLFQSV REVIQNPGPR HPEAASAAPP GASLLLLQQQ - 60
QQQQQQQQQQ QQQQQQQQET SPRQQQQQQG EDGSPQAHRR GPTGYLVLDE EQQPSQPQSA - 120
LECHPERGCV PEPGAAVAAS KGLPQQLPAP PDEDDSAAPS TLSLLGPTFP GLSSCSADLK - 180
DILSEASTMQ LLQQQQQEAV SEGSSSGRAR EASGAPTSSK DNYLGGTSTI SDNAKELCKA - 240
VSVSMGLGVE ALEHLSPGEQ LRGDCMYAPL LGVPPAVRPT PCAPLAECKG SLLDDSAGKS - 300
TEDTAEYSPF KGGYTKGLEG ESLGCSGSAA AGSSGTLELP STLSLYKSGA LDEAAAYQSR - 360
DYYNFPLALA GPPPPPPPPH PHARIKLENP LDYGSAWAAA AAQCRYGDLA SLHGAGAAGP - 420
GSGSPSAAAS SSWHTLFTAE EGQLYGPCGG GGGGGGGGGG GGGGGGGGGG GGEAGAVAPY - 480
GYTRPPQGLA GQESDFTAPD VWYPGGMVSR VPYPSPTCVK SEMGPWMDSY SGPYGDMRLE - 540
TARDHVLPID YYFPPQKTCL ICGDEASGCH YGALTCGSCK VFFKRAAEGK QKYLCASRND - 600
CTIDKFRRKN CPSCRLRKCY EAGMTLGARK LKKLGNLKLQ EEGEASSTTS PTEETTQKLT - 660
VSHIEGYECQ PIFLNVLEAI EPGVVCAGHD NNQPDSFAAL LSSLNELGER QLVHVVKWAK - 720
ALPGFRNLHV DDQMAVIQYS WMGLMVFAMG WRSFTNVNSR MLYFAPDLVF NEYRMHKSRM - 780
YSQCVRMRHL SQEFGWLQIT PQEFLCMKAL LLFSIIPVDG LKNQKFFDEL RMNYIKELDR - 840
IIACKRKNPT SCSRRFYQLT KLLDSVQPIA RELHQFTFDL LIKSHMVSVD FPEMMAEIIS - 900
VQVPKILSGK VKPIYFHTQ



Functional narrative    

The actions of androgens are mediated through the androgen receptor (AR), an intracellular receptor that belongs to the steroid nuclear receptor superfamily. The actions of male sex hormones testosterone and dihydrotestosterone are facilitated by the AR. Consisting of three domains, androgen receptor contains the ligand binding domain (LBD), the DNA binding domain (DBD), and the amino terminal domain (NTD). At the C-terminus, the LBD (amino acids 663-919) is responsible for dimerization, androgen binding, and ligand dependent transactivation. The DBD (amino acids 548-612) controls recognition of, and binding to DNA target sequences and receptor dimerization. At the amino terminal end, the NTD (amino acids 142-485) is critical for transactivation, and protein interactions with the LBD. Binding of the NTD to its target protein transcription factor (TFIIF) results in a disorder to order transition, creating more stability within the structure. The largest stretch of glutamines [within the NTD] is of particular interest because expansion of this sequence from on-average 22 to greater than 40 residues results in the neuromuscular degenerative condition spinal bulbar muscular atrophy or Kennedy's Disease. In addition, polymorphisms in this polyglutamine stretch have been associated with prostate cancer risk, male infertility, and rheumatoid arthritis. Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3.

Region 1: 142-485 Region 2: 548-612 Region 3: 663-919

Map of ordered and disordered regions







Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.


Region 1
Type:Disordered
Name:AF1 domain, Amino Terminal Domain (NTD)
Location:142 - 485
Length:344
Region sequence:

GLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVS
EGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQL
RGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGE
SLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHP
HARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEE
GQLYGPCGGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRP

Modification type: Engineered
Fragment
Monomeric
Native
PDB:  
Structural/functional type: Function arises via a disorder to order transition
Functional classes: Modification site
Molecular recognition effectors
Molecular assembly
Functional subclasses: Transactivation (transcriptional activation)
Phosphorylation
Protein-protein binding
Detection methods:
  1. Sensitivity to proteolysis (pH: 7.9; CaCl2 20 mM; EDTA 0.2 mM; glycerol 10 %; HEPES 25 mM; KCl 60 mM; MgCl2 5 mM)

  2. Fluorescence, intrinsic

  3. Circular dichroism (CD) spectroscopy, far-UV (293 K; dithiothreitol 1 mM; Na2HPO4 6 mM; NaH2PO4 4 mM; sodium sulfate 100 mM)

References:
  1. Kumar R, Betney R, Li J, Thompson EB, McEwan IJ. "Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF." Biochemistry. 2004; 43(11): 3008-13. PubMed: 15023052

  2. Reid J, Kelly SM, Watt K, Price NC, McEwan IJ. "Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions." J Biol Chem. 2002; 277(22): 20079-86. PubMed: 11896058

Comments:
Binding of NTD to target protein TFIIF transcription factor induces folding into a more stable conformation.




Region 2
Type:Ordered
Name:DNA Binding Domain
Location:548 - 612
Length:65
Region sequence:

PIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFR
RKNCP

Modification type:  
PDB:  
Structural/functional type: Function arises from the ordered state
Functional classes:  
Functional subclasses: Protein-DNA binding
Detection methods:
  1. X-ray crystallography

References:
  1. Reid J, Kelly SM, Watt K, Price NC, McEwan IJ. "Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions." J Biol Chem. 2002; 277(22): 20079-86. PubMed: 11896058

Comments:
 



Region 3
Type:Ordered
Name:Ligand Binding Domain
Location:663 - 919
Length:257
Region sequence:

HIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKAL
PGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYS
QCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRII
ACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQ
VPKILSGKVKPIYFHTQ

Modification type:  
PDB:  
Structural/functional type: Function arises from the ordered state
Functional classes:  
Functional subclasses: Protein-protein binding
Detection methods:
  1. X-ray crystallography

References:
  1. Reid J, Kelly SM, Watt K, Price NC, McEwan IJ. "Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions." J Biol Chem. 2002; 277(22): 20079-86. PubMed: 11896058

Comments:
 



References

  1. Jenster G, van der Korput HA, Trapman J, Brinkmann AO. "Identification of two transcription activation units in the N-terminal domain of the human androgen receptor." J Biol Chem. 1995; 270(13): 7341-6. PubMed: 7706276

  2. Simental JA, Sar M, Lane MV, French FS, Wilson EM. "Transcriptional activation and nuclear targeting signals of the human androgen receptor." J Biol Chem. 1991; 266(1): 510-8. PubMed: 1985913


If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us.


Disprot-footer
Contact us